Is Oral Administration of Chinese Herbal Medicine Effective and Safe as an Adjunctive Therapy for Managing Diabetic Foot Ulcers? A Systematic Review and Meta-Analysis
- 1 August 2010
- journal article
- review article
- Published by Mary Ann Liebert Inc in The Journal of Alternative and Complementary Medicine
- Vol. 16 (8) , 889-898
- https://doi.org/10.1089/acm.2009.0470
Abstract
Objective: This meta-analysis aimed to assess the effectiveness and safety of Chinese herbal medicine (CHM) as an adjunctive method to standard therapy for patients with diabetic foot ulcers (DFU). Methods: Randomized controlled trials (RCTs) of CHM to treat DFU were searched in the following electronic databases: MEDLINE®; EMBASE; Chinese Biomedical Database (CBM); Cochrane Central Register of Controlled Trials (CENTRAL); Allied & Complementary Medicine Resources (AMED); and Cumulative Index to Nursing and Allied Health Literature (CINAHL). Two (2) researchers independently assessed the quality and validity of included trials and extracted outcome data for synthesis. Results: Six (6) trials were included for analysis. Compared to using standard therapy alone, CHM combined with standard therapy significantly increased the number of patients whose ulcers healed (risk ratio [RR], 0.62, [95% confidence interval (CI), 0.39–0.97]) and number of patients with at least a 30% reduction in the ulcer area (RR, 0.81 [95%CI, 0.71–0.92]). In addition, the two therapies combined significantly decreased the number of patients without any improvement (RR, 0.34 [95%CI, 0.21–0.53]). However, with respect to blood flow volume in the dorsal artery of the foot, no significant difference between the two therapies was observed (standardized mean difference, 1.71 [95% CI −1.25–4.67]), but the result favored the CHM combined with standard therapy group. Only 2 of 6 trials reported adverse events, which included nausea, epigastric pain, and dry mouth. Conclusions: CHM may be effective and safe as an adjunctive therapy for treating DFU. However, a firm conclusion could not be reached because of the poor quality of the included trials. Further trials with higher quality are justified.Keywords
This publication has 23 references indexed in Scilit:
- Radix Astragali and Radix Rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability‐promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissuesPhytotherapy Research, 2009
- Effects of the preoperative administration of Yunnan Baiyao capsules on intraoperative blood loss in bimaxillary orthognathic surgery: A prospective, randomized, double-blind, placebo-controlled studyInternational Journal of Oral & Maxillofacial Surgery, 2009
- In vitro antidiabetic activities of five medicinal herbs used in Chinese medicinal formulaePhytotherapy Research, 2008
- The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: A Survey of 13 Randomly Selected Journals from Mainland ChinaClinical Therapeutics, 2007
- Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wardsBritish Journal of Clinical Pharmacology, 2007
- The Prevalence and Occurrence of Diabetic Foot Ulcer Pain and Its Impact on Health-Related Quality of LifeThe Journal of Pain, 2006
- Neuropathic Diabetic Foot UlcersNew England Journal of Medicine, 2004
- ABC of diabetes: The diabetic footBMJ, 2003
- Epidemiology of lower extremity amputation in centres in Europe, North America and East AsiaBritish Journal of Surgery, 2000
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996